4D Pharma PLC
LSE:DDDD
4D Pharma PLC
LSE:DDDD
Price:
16.66
GBX
5.04%
Market Closed
Market Cap:
£30m
Balance Sheet
Balance Sheet Decomposition
4D Pharma PLC
4D Pharma PLC
Balance Sheet Decomposition is not available for
4D Pharma PLC
4D Pharma PLC
Balance Sheet
4D Pharma PLC
4D Pharma PLC
Currency: GBP
| Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
0
|
0
|
29
|
2
|
29
|
12
|
16
|
4
|
9
|
15
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
29
|
2
|
29
|
12
|
16
|
4
|
9
|
15
|
|
| Short-Term Investments |
0
|
0
|
3
|
84
|
40
|
38
|
10
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
3
|
3
|
4
|
5
|
6
|
4
|
8
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
2
|
3
|
3
|
1
|
1
|
3
|
2
|
|
| Total Current Assets |
0
|
0
|
33
|
90
|
75
|
58
|
33
|
11
|
17
|
25
|
|
| PP&E Net |
0
|
0
|
0
|
1
|
4
|
5
|
5
|
5
|
4
|
4
|
|
| PP&E Gross |
0
|
0
|
0
|
1
|
4
|
5
|
5
|
5
|
4
|
4
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
1
|
1
|
2
|
3
|
4
|
5
|
|
| Intangible Assets |
0
|
0
|
3
|
3
|
5
|
5
|
5
|
5
|
5
|
5
|
|
| Goodwill |
0
|
0
|
3
|
3
|
9
|
9
|
9
|
9
|
9
|
9
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
3
|
3
|
9
|
9
|
9
|
9
|
9
|
9
|
|
| Total Assets |
0
N/A
|
1
+112%
|
39
+7 300%
|
97
+148%
|
93
-4%
|
78
-17%
|
53
-32%
|
31
-42%
|
35
+16%
|
43
+21%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
1
|
3
|
1
|
2
|
2
|
1
|
3
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
1
|
1
|
2
|
2
|
5
|
2
|
3
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
3
|
1
|
2
|
0
|
1
|
1
|
|
| Total Current Liabilities |
0
|
1
|
2
|
4
|
5
|
5
|
5
|
6
|
6
|
5
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
10
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
1
|
2
|
1
|
0
|
0
|
5
|
|
| Total Liabilities |
0
N/A
|
1
+2 000%
|
2
+257%
|
5
+109%
|
7
+42%
|
8
+19%
|
7
-14%
|
8
+21%
|
7
-10%
|
20
+165%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
0
|
1
|
1
|
9
|
19
|
39
|
63
|
87
|
109
|
163
|
|
| Additional Paid In Capital |
1
|
1
|
38
|
102
|
106
|
108
|
108
|
108
|
136
|
186
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
|
| Total Equity |
0
N/A
|
0
N/A
|
37
N/A
|
93
+151%
|
86
-7%
|
70
-19%
|
46
-34%
|
22
-51%
|
28
+25%
|
23
-17%
|
|
| Total Liabilities & Equity |
0
N/A
|
1
+112%
|
39
+7 300%
|
97
+148%
|
93
-4%
|
78
-17%
|
53
-32%
|
31
-42%
|
35
+16%
|
43
+21%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
37
|
37
|
52
|
64
|
65
|
65
|
65
|
65
|
131
|
180
|
|
Switch to:
Switch to:
See Also
Discover More
